AFIB Insider Trading Activity and SEC Form 4 Filings
AFIB insider trading summary
No open-market insider purchases or sales of Acutus Medical, Inc. (AFIB) have been reported on SEC Form 4 in the past 12 months.
Latest AFIB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 3, 2022 | R Scott Huennekens | Director | Sell | $35K (60,000 @ $0.58) |
| Nov 15, 2021 | James F. Hinrichs | Director | Buy | $151K (40,000 @ $3.78) |
| Jul 19, 2021 | Deerfield Mgmt III, L.P. | Director | Buy | $5.5M (390,836 @ $14.00) |
| Jul 19, 2021 | James E Flynn | Director | Buy | $5.5M (390,836 @ $14.00) |
| Jul 19, 2021 | Deerfield Private Design Fund III, L.P. | Director | Buy | $5.5M (390,836 @ $14.00) |
| Jul 19, 2021 | Deerfield Private Design Fund III, L.P. | Director | Buy | $9.5M (680,592 @ $14.00) |
| Jul 19, 2021 | Deerfield Management Company, L.P. (series C) | Director | Buy | $9.5M (680,592 @ $14.00) |
| Jul 19, 2021 | Deerfield Mgmt III, L.P. | Director | Buy | $9.5M (680,592 @ $14.00) |
| Jul 19, 2021 | Deerfield Partners, L.P. | Director | Buy | $9.5M (680,592 @ $14.00) |
| Jul 19, 2021 | Deerfield Management Company, L.P. (series C) | Director | Buy | $5.5M (390,836 @ $14.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.